BioXcel Therapeutics, Inc.
BTAI
$1.88
$0.02991.62%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -26.08% | -28.23% | -24.10% | 13.68% | -27.50% |
| Total Receivables | 4,266.67% | -99.63% | 114.81% | 432.39% | -90.34% |
| Inventory | -55.48% | -43.10% | 9.88% | 22.50% | -1.34% |
| Prepaid Expenses | 18.11% | 61.41% | 31.95% | -24.41% | -27.80% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 3.00% | -14.91% | -11.48% | -10.68% | -4.28% |
| Total Current Assets | -21.76% | -25.54% | -20.68% | 12.16% | -26.93% |
|
|
|||||
| Total Current Assets | -21.76% | -25.54% | -20.68% | 12.16% | -26.93% |
| Net Property, Plant & Equipment | -15.40% | -13.20% | -11.52% | -10.39% | -9.36% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Assets | -21.59% | -25.28% | -20.51% | 11.70% | -26.63% |
|
|
|||||
| Total Accounts Payable | 7.39% | 12.32% | -23.02% | 26.12% | 27.98% |
| Total Accrued Expenses | -32.57% | -36.50% | -1.55% | 4.23% | -52.46% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.63% | 1.94% | 2.27% | -- | -- |
| Total Finance Division Other Current Liabilities | -94.74% | 877.97% | -11.94% | -56.49% | -37.14% |
| Total Other Current Liabilities | -94.74% | 877.97% | -11.94% | -56.49% | -37.14% |
| Total Current Liabilities | -13.01% | -6.34% | -13.32% | 15.45% | -30.81% |
|
|
|||||
| Total Current Liabilities | -13.01% | -6.34% | -13.32% | 15.45% | -30.81% |
| Long-Term Debt | -1.85% | 1.39% | 1.35% | 1.03% | 1.52% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -59.63% | -37.11% | -26.86% | -20.45% | -16.82% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 51.89% | -52.46% | -56.71% | 1,014.02% | -6.02% |
| Total Liabilities | -2.29% | -3.73% | -9.66% | 18.80% | -7.69% |
|
|
|||||
| Common Stock & APIC | 0.61% | 0.42% | 1.17% | 2.05% | 1.20% |
| Retained Earnings | -1.70% | -2.18% | -1.34% | -4.54% | -3.92% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -8.72% | -15.25% | -2.68% | -28.06% | -39.15% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -8.72% | -15.25% | -2.68% | -28.06% | -39.15% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -8.72% | -15.25% | -2.68% | -28.06% | -39.15% |
|
|
|||||